AngioDynamics Completes Acquisition of Microsulis Medical

Fri Feb 1, 2013 6:30am EST

* Reuters is not responsible for the content in this press release.

http://pdf.reuters.com/htmlnews/8knews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130201:nGNXUXBUGa

ALBANY, N.Y., Feb. 1, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of
innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular
disease and oncology, today said it has completed the previously announced acquisition of certain
assets of Microsulis Medical Ltd.

Microsulis developed the Acculis MTA microwave ablation system, which utilizes a single,
high-power, high-frequency 2.45 GHz saline-cooled applicator that may provide advantages to
clinicians and patients, including faster ablation of soft tissue.

"We are excited to welcome the Microsulis team to AngioDynamics," said Joseph M. DeVivo, President
and CEO of AngioDynamics. "With the addition of microwave, we have a complete offering of thermal
and non-thermal technologies, further building on our status as a market-leader in the $250
million global tissue ablation market."

About AngioDynamics 

AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by
professional healthcare providers for vascular access, surgery, peripheral vascular disease and
oncology. AngioDynamics' diverse product lines include market-leading ablation systems, fluid
management systems, vascular access products, angiographic products and accessories, angioplasty
products, drainage products, thrombolytic products and venous products. More information is
available at www.AngioDynamics.com
http://www.globenewswire.com/newsroom/ctr?d=10020225&l=5&a=www.AngioDynamics.com&u=http%3A%2F%2Fwww.angiodynamics.com%2F
.

Trademarks

AngioDynamics, the AngioDynamics logo and Acculis are trademarks and/or registered trademarks of
AngioDynamics Inc., an affiliate or a subsidiary.

CONTACT: Company Contact:
         AngioDynamics, Inc.
         Mark Frost, CFO
         (800) 772-6446 x1981
         mfrost@AngioDynamics.com
         
         Investor Relations Contacts:
         EVC Group, Inc.
         Greg Gin/Robert Jones
         (646) 445-4801; (646) 201-5447
         ggin@evcgroup.com; bjones@evcgroup.com
         
         Media Contact:
         EVC Group, Inc.
         Amy Phillips
         (412) 327-9499
         aphillips@evcgroup.com

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.